Clinical trial
Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment, a UK, Multi-center, Single Arm, Prospective Observational Study
NCT03423290 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment, a UK, Multi-center, Single Arm, Prospective Observational Study
- Lead sponsor
- Microvention-Terumo, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 23, 2017
- Completion date
- January 26, 2022
- Enrollment
- 61 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.